Sfoglia per Titolo
Tumor Necrosis Factor-Alpha at the Crossroad between Rheumatoid Arthritis and Autoimmune Cholangitis
2015-01-01 Selmi, C.; Generali, E.; Cantarini, L.
Tumor necrosis factor-alpha inhibitor therapy in erosive polyarthritis secondary to systemic sclerosis
2005-01-01 Bosello, Silvia; De Santis, Maria; Tolusso, Barbara; Zoli, Angelo; Ferraccioli, Gianfranco
Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: Tipping the balance
2007-01-01 Danese, S; Pagano, N; Angelucci, E; Stefanelli, T; Repici, A; Omodei, P; Daperno, M; Malesci, A
Tumor regression grade of gastric carcinoma after neoadjuvant chemotherapy: Which classification?
2013-01-01 Chiari, D; E., Orsenigo; L., Albarello; C., Socci; P., Gazzetta; M., Bissolati; E., Mazza; C., Staudacher
Tumor segmentation and quantitative assessment of glucose metabolism for different histological types of NSCLC using dynamic F-18-FDG PET
2016-01-01 Meijer, T; De Geus-Oei, Lf; Visser, E; Oyen, W; Looijen-Salamon, M; Visvikis, D; Verhagen, A; Bussink, J; Vriens, D
Tumor size as a prognostic factor in patients with stage IIa colon cancer
2017-01-01 Santullo, F; Biondi, A; Cananzi, F; Fico, V; Tirelli, F; Ricci, R; Rizzo, G; Coco, C; Mattana, C; D'Ugo, D; Persiani, R.
Tumor Size is a Determinant of the Rate of Stage T1 Renal Cell Cancer Synchronous Metastasis
2009-01-01 Lughezzani, G; Jeldres, C; Isbarn, H; Perrotte, P; Shariat, Sf; Sun, M; Widmer, H; Arjane, P; Peloquin, F; Pharand, D; Patard, Jj; Graefen, M; Montorsi, F; Karakiewicz, Pi
TUMOR SIZE IS ASSOCIATED WITH THE RATE OF SYNCHRONOUS METASTASES IN PATIENTS WITH SMALL RENAL CELL TUMORS
2010-01-01 Lughezzani, G; Jeldres, C; Budaus, L; Shariat, Sf; Sun, M; Liberman, D; Thuret, R; Arjane, P; Widmer, H; Graefen, M; Perrotte, P; Montorsi, F; Karakiewicz, Pi
Tumor suppression by means of microenvironment-mediated stress response: the role of the human RNASET2 gene
2013-01-01 Acquati, F; Lualdi, M; Bertilaccio, S; Monti, L; Pedrini, E; Turconi, G; Grimaldi, A; Fabbri, M; Anselmo, A; Inforzato, A; Riva, C; Gribaldo, L; Ghia, P; Taramelli, R
Tumor Targeting Using Radiolabeled Antibodies for Image-Guided Drug Delivery
2015-01-01 Rijpkema, M; Boerman, Oc; Oyen, W
Tumor targeting with a monomeric, dimeric and tetrameric RGD peptide
2006-01-01 Dijkgraaf, I; Frielink, C; Kruytzer, J; Oyen, W; Liskamp, R; Corstens, Fhm; Boerman, Oc
Tumor targeting with alpha(v)beta(3) integrin binding peptides
2003-01-01 Boerman, Oc; Oyen, W; Frielink, C; Dijkgraaf, I; Harris, Td; Edwards, Ds; Corstens, Fhm
Tumor targeting with radiolabeled alfavbeta3 integrin binding RGD peptides in a nude mouse model
2001-01-01 Boerman, Oc; Janssen, M; Frielink, C; Oyen, W; Edwards, S; Rajopadhye, M; Corstens, F
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model
2002-01-01 Janssen, Ml; Oyen, W; Dijkgraaf, I; Massuger, Lf; Frielink, C; Edwards, Ds; Rajopadhye, M; Boonstra, H; Corstens, Fh; Boerman, Oc
Tumor targeting with radiolabeled integrin alpha(v beta 3) binding RGD peptides in a nude mouse tumor model.
2001-01-01 Janssen, M; Oyen, W; Edwards, D; Barret, J; Rajopadhye, M; Liu, S; Bartis, J; Massuger, L; Boonstra, H; Corstens, F; Boerman, O
Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of F-18-FDG-PET based tumor segmentation in head and neck squamous cell carcinoma in a multicenter setting
2019-01-01 van den Bosch, S; Dijkema, T; Philippens, Mep; Terhaard, Chj; Hoebers, Fjp; Kaanders, Jham; Oyen, W
Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulations
2022-01-01 Mannarino, Laura; Mirimao, Federica; Panini, Nicolò; Paracchini, Lara; Marchini, Sergio; Beltrame, Luca; Amodeo, Rosy; Grosso, Federica; Libener, Roberta; De Simone, Irene; Ceresoli, Giovanni L; Zucali, Paolo A; Lupi, Monica; D'Incalci, Maurizio
Tumor uptake and tumor retention of a monomeric and a dimeric Tc-99m-labeled RGD-peptide
2001-01-01 Boerman, Oc; Janssen, M; Frielink, C; Oyen, W; Edwards, S; Liu, S; Rajopadhye, M; Corstens, F
Tumor Volume and Clinical Failure in High-Risk Prostate Cancer Patients Treated With Radical Prostatectomy
2017-01-01 Castiglione, F; Dell'Oglio, P; Tosco, L; Everaerts, W; Albersen, M; Hakim, L; Van den Broeck, T; Moris, L; Claessens, F; Briganti, A; Montorsi, F; Van Poppel, H; Joniau, S
Tumor-associated leukocytes: Biological and therapeutic significance
1993-01-01 Mantovani, A; Bottazzi, B; Sozzani, S; Peri, G; Allavena, P; Garlanda, C; Vecchi, A; Colotta, F
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Tumor Necrosis Factor-Alpha at the Crossroad between Rheumatoid Arthritis and Autoimmune Cholangitis | 1-gen-2015 | Selmi, C.; Generali, E.; Cantarini, L. | |
Tumor necrosis factor-alpha inhibitor therapy in erosive polyarthritis secondary to systemic sclerosis | 1-gen-2005 | Bosello, Silvia; De Santis, Maria; Tolusso, Barbara; Zoli, Angelo; Ferraccioli, Gianfranco | |
Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: Tipping the balance | 1-gen-2007 | Danese, S; Pagano, N; Angelucci, E; Stefanelli, T; Repici, A; Omodei, P; Daperno, M; Malesci, A | |
Tumor regression grade of gastric carcinoma after neoadjuvant chemotherapy: Which classification? | 1-gen-2013 | Chiari, D; E., Orsenigo; L., Albarello; C., Socci; P., Gazzetta; M., Bissolati; E., Mazza; C., Staudacher | |
Tumor segmentation and quantitative assessment of glucose metabolism for different histological types of NSCLC using dynamic F-18-FDG PET | 1-gen-2016 | Meijer, T; De Geus-Oei, Lf; Visser, E; Oyen, W; Looijen-Salamon, M; Visvikis, D; Verhagen, A; Bussink, J; Vriens, D | |
Tumor size as a prognostic factor in patients with stage IIa colon cancer | 1-gen-2017 | Santullo, F; Biondi, A; Cananzi, F; Fico, V; Tirelli, F; Ricci, R; Rizzo, G; Coco, C; Mattana, C; D'Ugo, D; Persiani, R. | |
Tumor Size is a Determinant of the Rate of Stage T1 Renal Cell Cancer Synchronous Metastasis | 1-gen-2009 | Lughezzani, G; Jeldres, C; Isbarn, H; Perrotte, P; Shariat, Sf; Sun, M; Widmer, H; Arjane, P; Peloquin, F; Pharand, D; Patard, Jj; Graefen, M; Montorsi, F; Karakiewicz, Pi | |
TUMOR SIZE IS ASSOCIATED WITH THE RATE OF SYNCHRONOUS METASTASES IN PATIENTS WITH SMALL RENAL CELL TUMORS | 1-gen-2010 | Lughezzani, G; Jeldres, C; Budaus, L; Shariat, Sf; Sun, M; Liberman, D; Thuret, R; Arjane, P; Widmer, H; Graefen, M; Perrotte, P; Montorsi, F; Karakiewicz, Pi | |
Tumor suppression by means of microenvironment-mediated stress response: the role of the human RNASET2 gene | 1-gen-2013 | Acquati, F; Lualdi, M; Bertilaccio, S; Monti, L; Pedrini, E; Turconi, G; Grimaldi, A; Fabbri, M; Anselmo, A; Inforzato, A; Riva, C; Gribaldo, L; Ghia, P; Taramelli, R | |
Tumor Targeting Using Radiolabeled Antibodies for Image-Guided Drug Delivery | 1-gen-2015 | Rijpkema, M; Boerman, Oc; Oyen, W | |
Tumor targeting with a monomeric, dimeric and tetrameric RGD peptide | 1-gen-2006 | Dijkgraaf, I; Frielink, C; Kruytzer, J; Oyen, W; Liskamp, R; Corstens, Fhm; Boerman, Oc | |
Tumor targeting with alpha(v)beta(3) integrin binding peptides | 1-gen-2003 | Boerman, Oc; Oyen, W; Frielink, C; Dijkgraaf, I; Harris, Td; Edwards, Ds; Corstens, Fhm | |
Tumor targeting with radiolabeled alfavbeta3 integrin binding RGD peptides in a nude mouse model | 1-gen-2001 | Boerman, Oc; Janssen, M; Frielink, C; Oyen, W; Edwards, S; Rajopadhye, M; Corstens, F | |
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model | 1-gen-2002 | Janssen, Ml; Oyen, W; Dijkgraaf, I; Massuger, Lf; Frielink, C; Edwards, Ds; Rajopadhye, M; Boonstra, H; Corstens, Fh; Boerman, Oc | |
Tumor targeting with radiolabeled integrin alpha(v beta 3) binding RGD peptides in a nude mouse tumor model. | 1-gen-2001 | Janssen, M; Oyen, W; Edwards, D; Barret, J; Rajopadhye, M; Liu, S; Bartis, J; Massuger, L; Boonstra, H; Corstens, F; Boerman, O | |
Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of F-18-FDG-PET based tumor segmentation in head and neck squamous cell carcinoma in a multicenter setting | 1-gen-2019 | van den Bosch, S; Dijkema, T; Philippens, Mep; Terhaard, Chj; Hoebers, Fjp; Kaanders, Jham; Oyen, W | |
Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulations | 1-gen-2022 | Mannarino, Laura; Mirimao, Federica; Panini, Nicolò; Paracchini, Lara; Marchini, Sergio; Beltrame, Luca; Amodeo, Rosy; Grosso, Federica; Libener, Roberta; De Simone, Irene; Ceresoli, Giovanni L; Zucali, Paolo A; Lupi, Monica; D'Incalci, Maurizio | |
Tumor uptake and tumor retention of a monomeric and a dimeric Tc-99m-labeled RGD-peptide | 1-gen-2001 | Boerman, Oc; Janssen, M; Frielink, C; Oyen, W; Edwards, S; Liu, S; Rajopadhye, M; Corstens, F | |
Tumor Volume and Clinical Failure in High-Risk Prostate Cancer Patients Treated With Radical Prostatectomy | 1-gen-2017 | Castiglione, F; Dell'Oglio, P; Tosco, L; Everaerts, W; Albersen, M; Hakim, L; Van den Broeck, T; Moris, L; Claessens, F; Briganti, A; Montorsi, F; Van Poppel, H; Joniau, S | |
Tumor-associated leukocytes: Biological and therapeutic significance | 1-gen-1993 | Mantovani, A; Bottazzi, B; Sozzani, S; Peri, G; Allavena, P; Garlanda, C; Vecchi, A; Colotta, F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile